Fight fat with an asthma drug: Neothetics sets terms for $60 million IPO – Nasdaq

Fight fat with an asthma drug: Neothetics sets terms for $60 million IPO
Nasdaq
Neothetics, a biotech targeting fat reduction with an injectable formulation of an approved asthma drug, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $60 million by offering 4.3 million shares at a price range …

and more »